Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-27 to 2023-03-20
Current total value of award: $24614.64
Description: 4560107000!NEXPLANON 68 MG IMPLANTS